The FDA has granted Anaheim, Calif.-based ClearFlow 510(k) clearance for its FlowGlide active clearance technology system, a device intended for preventing retained blood syndrome by reducing or preventing occlusion of chest drains with clots.
ClearFlow's active clearance technology system wins FDA clearance
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.